197 related articles for article (PubMed ID: 9774693)
1. Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation.
Danial NN; Losman JA; Lu T; Yip N; Krishnan K; Krolewski J; Goff SP; Wang JY; Rothman PB
Mol Cell Biol; 1998 Nov; 18(11):6795-804. PubMed ID: 9774693
[TBL] [Abstract][Full Text] [Related]
2. JAK-STAT signaling activated by Abl oncogenes.
Danial NN; Rothman P
Oncogene; 2000 May; 19(21):2523-31. PubMed ID: 10851051
[TBL] [Abstract][Full Text] [Related]
3. Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells.
Oki S; Limnander A; Danial NN; Rothman PB
Blood; 2002 Aug; 100(3):966-73. PubMed ID: 12130510
[TBL] [Abstract][Full Text] [Related]
4. Jak-STAT signaling induced by the v-abl oncogene.
Danial NN; Pernis A; Rothman PB
Science; 1995 Sep; 269(5232):1875-7. PubMed ID: 7569929
[TBL] [Abstract][Full Text] [Related]
5. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
Zhang Y; Turkson J; Carter-Su C; Smithgall T; Levitzki A; Kraker A; Krolewski JJ; Medveczky P; Jove R
J Biol Chem; 2000 Aug; 275(32):24935-44. PubMed ID: 10823829
[TBL] [Abstract][Full Text] [Related]
6. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
7. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
8. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor.
Shimoda K; Feng J; Murakami H; Nagata S; Watling D; Rogers NC; Stark GR; Kerr IM; Ihle JN
Blood; 1997 Jul; 90(2):597-604. PubMed ID: 9226159
[TBL] [Abstract][Full Text] [Related]
9. v-Abl signaling disrupts SOCS-1 function in transformed pre-B cells.
Limnander A; Danial NN; Rothman PB
Mol Cell; 2004 Aug; 15(3):329-41. PubMed ID: 15304214
[TBL] [Abstract][Full Text] [Related]
10. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
11. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway.
Stancato LF; Sakatsume M; David M; Dent P; Dong F; Petricoin EF; Krolewski JJ; Silvennoinen O; Saharinen P; Pierce J; Marshall CJ; Sturgill T; Finbloom DS; Larner AC
Mol Cell Biol; 1997 Jul; 17(7):3833-40. PubMed ID: 9199317
[TBL] [Abstract][Full Text] [Related]
12. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
[TBL] [Abstract][Full Text] [Related]
13. A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.
Guschin D; Rogers N; Briscoe J; Witthuhn B; Watling D; Horn F; Pellegrini S; Yasukawa K; Heinrich P; Stark GR
EMBO J; 1995 Apr; 14(7):1421-9. PubMed ID: 7537214
[TBL] [Abstract][Full Text] [Related]
14. Abl oncogene bypasses normal regulation of Jak/STAT activation.
Limnander A; Rothman PB
Cell Cycle; 2004 Dec; 3(12):1486-8. PubMed ID: 15611644
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
Chai SK; Nichols GL; Rothman P
J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
[TBL] [Abstract][Full Text] [Related]
16. Jak1 deficiency leads to enhanced Abelson-induced B-cell tumor formation.
Sexl V; Kovacic B; Piekorz R; Moriggl R; Stoiber D; Hoffmeyer A; Liebminger R; Kudlacek O; Weisz E; Rothammer K; Ihle JN
Blood; 2003 Jun; 101(12):4937-43. PubMed ID: 12576323
[TBL] [Abstract][Full Text] [Related]
17. Rac is required for v-Abl tyrosine kinase to activate mitogenesis.
Renshaw MW; Lea-Chou E; Wang JY
Curr Biol; 1996 Jan; 6(1):76-83. PubMed ID: 8805224
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
Shuai K; Halpern J; ten Hoeve J; Rao X; Sawyers CL
Oncogene; 1996 Jul; 13(2):247-54. PubMed ID: 8710363
[TBL] [Abstract][Full Text] [Related]
19. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
20. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.
Reddy EP; Korapati A; Chaturvedi P; Rane S
Oncogene; 2000 May; 19(21):2532-47. PubMed ID: 10851052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
